IM156
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IM156, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer. [Phase 1]